119 related articles for article (PubMed ID: 9214428)
1. Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation.
Rosen F; McCabe G; Quach J; Solan J; Terkeltaub R; Seegmiller JE; Lotz M
Arthritis Rheum; 1997 Jul; 40(7):1275-81. PubMed ID: 9214428
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes.
Lotz M; Rosen F; McCabe G; Quach J; Blanco F; Dudler J; Solan J; Goding J; Seegmiller JE; Terkeltaub R
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10364-8. PubMed ID: 7479785
[TBL] [Abstract][Full Text] [Related]
3. Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging.
Hirose J; Masuda I; Ryan LM
Arthritis Rheum; 2000 Dec; 43(12):2703-11. PubMed ID: 11145028
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes.
Rosenthal AK; Henry LA
J Rheumatol; 1999 Feb; 26(2):395-401. PubMed ID: 9972975
[TBL] [Abstract][Full Text] [Related]
5. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist.
Johnson K; Farley D; Hu SI; Terkeltaub R
Arthritis Rheum; 2003 May; 48(5):1302-14. PubMed ID: 12746903
[TBL] [Abstract][Full Text] [Related]
6. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes.
Johnson K; Vaingankar S; Chen Y; Moffa A; Goldring MB; Sano K; Jin-Hua P; Sali A; Goding J; Terkeltaub R
Arthritis Rheum; 1999 Sep; 42(9):1986-97. PubMed ID: 10513816
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage.
Rosenthal AK; Cheung HS; Ryan LM
Arthritis Rheum; 1991 Jul; 34(7):904-11. PubMed ID: 1647773
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles.
Rosenthal AK; Derfus BA; Henry LA
Arthritis Rheum; 1997 May; 40(5):966-70. PubMed ID: 9153560
[TBL] [Abstract][Full Text] [Related]
10. Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage.
Rosenthal AK; Ryan LM
Mech Ageing Dev; 1994 Jul; 75(1):35-44. PubMed ID: 9128752
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization.
Johnson K; Jung A; Murphy A; Andreyev A; Dykens J; Terkeltaub R
Arthritis Rheum; 2000 Jul; 43(7):1560-70. PubMed ID: 10902761
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effects of vitamin D metabolites and transforming growth factor-beta on costochondral chondrocytes are mediated by increases in protein kinase C activity involving two separate pathways.
Schwartz Z; Sylvia VL; Dean DD; Boyan BD
Endocrinology; 1998 Feb; 139(2):534-45. PubMed ID: 9449622
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes.
Rosenthal AK; Henry LA
Calcif Tissue Int; 1996 Aug; 59(2):128-33. PubMed ID: 8687982
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related proteins is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate.
Terkeltaub R; Lotz M; Johnson K; Deng D; Hashimoto S; Goldring MB; Burton D; Deftos LJ
Arthritis Rheum; 1998 Dec; 41(12):2152-64. PubMed ID: 9870872
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta-1 stimulates articular chondrocyte elaboration of matrix vesicles capable of greater calcium pyrophosphate precipitation.
Derfus BA; Camacho NP; Olmez U; Kushnaryov VM; Westfall PR; Ryan LM; Rosenthal AK
Osteoarthritis Cartilage; 2001 Apr; 9(3):189-94. PubMed ID: 11300741
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of inorganic pyrophosphate elaboration in cartilage by serum factors.
Rosenthal AK; Cheung HS; Ryan LM
Arch Biochem Biophys; 1989 Aug; 272(2):386-92. PubMed ID: 2546498
[TBL] [Abstract][Full Text] [Related]
17. Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes.
Rosenthal AK; Ryan LM
J Rheumatol; 1994 May; 21(5):896-900. PubMed ID: 7520501
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells).
Terkeltaub RA; Johnson K; Rohnow D; Goomer R; Burton D; Deftos LJ
J Bone Miner Res; 1998 Jun; 13(6):931-41. PubMed ID: 9626624
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues.
Rosenthal AK; McCarty BA; Cheung HS; Ryan LM
Arthritis Rheum; 1993 Apr; 36(4):539-42. PubMed ID: 7681284
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
Studer RK; Georgescu HI; Miller LA; Evans CH
Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
